ENSTILAR: payments to doctors
Payments that named ENSTILAR as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $818K
- Providers
- 7,373
- Transactions
- 38,001
- Average per transaction
- $22
The per-transaction average — $22 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,373 providers the average total is $111, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| LEO Pharma Inc. | $758,617 | 92.7% |
| LEO Pharma AS | $59,435 | 7.3% |